Home Healthcare IT Intravenous to Subcutaneous Drug Repositioning Market Size, Share & Growth Graph by 2034

Intravenous to Subcutaneous Drug Repositioning Market Size, Share & Trends Analysis Report By Product (Devices, Drugs), By Therapeutic Indication (Cardiology, Oncology, Pulmonary Arterial Hypertension, Hematology, Others), By End User (Hospitals & Clinics, Research Facilities, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Report Code: SRHI681DR
Last Updated: Mar, 2026
Pages: 150
Author: Debashree Bora
Format: PDF, Excel

Market Segmentation

  1. Intravenous to Subcutaneous Drug Repositioning Market, By Product (2022-2034)
    1. Devices
      1. Wearable SC Injectors
      2. Wearable SC Infusers
    2. Drugs
      1. Cancer Drugs
      2. Blood Factors
      3. Immunoglobulin G
      4. Antibiotics
      5. Remodulin
      6. Others
  2. Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic Indication (2022-2034)
    1. Cardiology
    2. Oncology
    3. Pulmonary Arterial Hypertension
    4. Hematology
    5. Others
  3. Intravenous to Subcutaneous Drug Repositioning Market, By End User (2022-2034)
    1. Hospitals & Clinics
    2. Research Facilities
    3. Others
    1. North America
      1. North America Intravenous to Subcutaneous Drug Repositioning Market, By Product
        1. Devices
          1. Wearable SC Injectors
            1. Wearable SC Infusers
            2. Drugs
              1. Cancer Drugs
                1. Blood Factors
                  1. Immunoglobulin G
                    1. Antibiotics
                      1. Remodulin
                        1. Others
                      2. North America Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic Indication
                        1. Cardiology
                          1. Oncology
                            1. Pulmonary Arterial Hypertension
                              1. Hematology
                                1. Others
                                2. North America Intravenous to Subcutaneous Drug Repositioning Market, By End User
                                  1. Hospitals & Clinics
                                    1. Research Facilities
                                      1. Others
                                      2. U.S.
                                        1. U.S. Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                          1. Devices
                                            1. Wearable SC Injectors
                                              1. Wearable SC Infusers
                                              2. Drugs
                                                1. Cancer Drugs
                                                  1. Blood Factors
                                                    1. Immunoglobulin G
                                                      1. Antibiotics
                                                        1. Remodulin
                                                          1. Others
                                                        2. U.S. Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic Indication
                                                          1. Cardiology
                                                            1. Oncology
                                                              1. Pulmonary Arterial Hypertension
                                                                1. Hematology
                                                                  1. Others
                                                                  2. U.S. Intravenous to Subcutaneous Drug Repositioning Market, By End User
                                                                    1. Hospitals & Clinics
                                                                      1. Research Facilities
                                                                        1. Others
                                                                      2. Canada
                                                                    2. Europe
                                                                      1. Europe Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                        1. Devices
                                                                          1. Wearable SC Injectors
                                                                            1. Wearable SC Infusers
                                                                            2. Drugs
                                                                              1. Cancer Drugs
                                                                                1. Blood Factors
                                                                                  1. Immunoglobulin G
                                                                                    1. Antibiotics
                                                                                      1. Remodulin
                                                                                        1. Others
                                                                                      2. Europe Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic Indication
                                                                                        1. Cardiology
                                                                                          1. Oncology
                                                                                            1. Pulmonary Arterial Hypertension
                                                                                              1. Hematology
                                                                                                1. Others
                                                                                                2. Europe Intravenous to Subcutaneous Drug Repositioning Market, By End User
                                                                                                  1. Hospitals & Clinics
                                                                                                    1. Research Facilities
                                                                                                      1. Others
                                                                                                      2. U.K.
                                                                                                        1. U.K. Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                          1. Devices
                                                                                                            1. Wearable SC Injectors
                                                                                                              1. Wearable SC Infusers
                                                                                                              2. Drugs
                                                                                                                1. Cancer Drugs
                                                                                                                  1. Blood Factors
                                                                                                                    1. Immunoglobulin G
                                                                                                                      1. Antibiotics
                                                                                                                        1. Remodulin
                                                                                                                          1. Others
                                                                                                                        2. U.K. Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic Indication
                                                                                                                          1. Cardiology
                                                                                                                            1. Oncology
                                                                                                                              1. Pulmonary Arterial Hypertension
                                                                                                                                1. Hematology
                                                                                                                                  1. Others
                                                                                                                                  2. U.K. Intravenous to Subcutaneous Drug Repositioning Market, By End User
                                                                                                                                    1. Hospitals & Clinics
                                                                                                                                      1. Research Facilities
                                                                                                                                        1. Others
                                                                                                                                      2. Germany
                                                                                                                                      3. France
                                                                                                                                      4. Spain
                                                                                                                                      5. Italy
                                                                                                                                      6. Russia
                                                                                                                                      7. Nordic
                                                                                                                                      8. Benelux
                                                                                                                                      9. Rest of Europe
                                                                                                                                    2. APAC
                                                                                                                                      1. APAC Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                        1. Devices
                                                                                                                                          1. Wearable SC Injectors
                                                                                                                                            1. Wearable SC Infusers
                                                                                                                                            2. Drugs
                                                                                                                                              1. Cancer Drugs
                                                                                                                                                1. Blood Factors
                                                                                                                                                  1. Immunoglobulin G
                                                                                                                                                    1. Antibiotics
                                                                                                                                                      1. Remodulin
                                                                                                                                                        1. Others
                                                                                                                                                      2. APAC Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic Indication
                                                                                                                                                        1. Cardiology
                                                                                                                                                          1. Oncology
                                                                                                                                                            1. Pulmonary Arterial Hypertension
                                                                                                                                                              1. Hematology
                                                                                                                                                                1. Others
                                                                                                                                                                2. APAC Intravenous to Subcutaneous Drug Repositioning Market, By End User
                                                                                                                                                                  1. Hospitals & Clinics
                                                                                                                                                                    1. Research Facilities
                                                                                                                                                                      1. Others
                                                                                                                                                                      2. China
                                                                                                                                                                        1. China Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                          1. Devices
                                                                                                                                                                            1. Wearable SC Injectors
                                                                                                                                                                              1. Wearable SC Infusers
                                                                                                                                                                              2. Drugs
                                                                                                                                                                                1. Cancer Drugs
                                                                                                                                                                                  1. Blood Factors
                                                                                                                                                                                    1. Immunoglobulin G
                                                                                                                                                                                      1. Antibiotics
                                                                                                                                                                                        1. Remodulin
                                                                                                                                                                                          1. Others
                                                                                                                                                                                        2. China Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic Indication
                                                                                                                                                                                          1. Cardiology
                                                                                                                                                                                            1. Oncology
                                                                                                                                                                                              1. Pulmonary Arterial Hypertension
                                                                                                                                                                                                1. Hematology
                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                  2. China Intravenous to Subcutaneous Drug Repositioning Market, By End User
                                                                                                                                                                                                    1. Hospitals & Clinics
                                                                                                                                                                                                      1. Research Facilities
                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                      2. Korea
                                                                                                                                                                                                      3. Japan
                                                                                                                                                                                                      4. India
                                                                                                                                                                                                      5. Australia
                                                                                                                                                                                                      6. Taiwan
                                                                                                                                                                                                      7. South East Asia
                                                                                                                                                                                                      8. Rest of Asia-Pacific
                                                                                                                                                                                                    2. Middle East and Africa
                                                                                                                                                                                                      1. Middle East and Africa Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                                                        1. Devices
                                                                                                                                                                                                          1. Wearable SC Injectors
                                                                                                                                                                                                            1. Wearable SC Infusers
                                                                                                                                                                                                            2. Drugs
                                                                                                                                                                                                              1. Cancer Drugs
                                                                                                                                                                                                                1. Blood Factors
                                                                                                                                                                                                                  1. Immunoglobulin G
                                                                                                                                                                                                                    1. Antibiotics
                                                                                                                                                                                                                      1. Remodulin
                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                      2. Middle East and Africa Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic Indication
                                                                                                                                                                                                                        1. Cardiology
                                                                                                                                                                                                                          1. Oncology
                                                                                                                                                                                                                            1. Pulmonary Arterial Hypertension
                                                                                                                                                                                                                              1. Hematology
                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                2. Middle East and Africa Intravenous to Subcutaneous Drug Repositioning Market, By End User
                                                                                                                                                                                                                                  1. Hospitals & Clinics
                                                                                                                                                                                                                                    1. Research Facilities
                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                      2. UAE
                                                                                                                                                                                                                                        1. UAE Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                                                                                          1. Devices
                                                                                                                                                                                                                                            1. Wearable SC Injectors
                                                                                                                                                                                                                                              1. Wearable SC Infusers
                                                                                                                                                                                                                                              2. Drugs
                                                                                                                                                                                                                                                1. Cancer Drugs
                                                                                                                                                                                                                                                  1. Blood Factors
                                                                                                                                                                                                                                                    1. Immunoglobulin G
                                                                                                                                                                                                                                                      1. Antibiotics
                                                                                                                                                                                                                                                        1. Remodulin
                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                        2. UAE Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic Indication
                                                                                                                                                                                                                                                          1. Cardiology
                                                                                                                                                                                                                                                            1. Oncology
                                                                                                                                                                                                                                                              1. Pulmonary Arterial Hypertension
                                                                                                                                                                                                                                                                1. Hematology
                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                  2. UAE Intravenous to Subcutaneous Drug Repositioning Market, By End User
                                                                                                                                                                                                                                                                    1. Hospitals & Clinics
                                                                                                                                                                                                                                                                      1. Research Facilities
                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                      1. LATAM Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                                                                                                                        1. Devices
                                                                                                                                                                                                                                                                          1. Wearable SC Injectors
                                                                                                                                                                                                                                                                            1. Wearable SC Infusers
                                                                                                                                                                                                                                                                            2. Drugs
                                                                                                                                                                                                                                                                              1. Cancer Drugs
                                                                                                                                                                                                                                                                                1. Blood Factors
                                                                                                                                                                                                                                                                                  1. Immunoglobulin G
                                                                                                                                                                                                                                                                                    1. Antibiotics
                                                                                                                                                                                                                                                                                      1. Remodulin
                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                      2. LATAM Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic Indication
                                                                                                                                                                                                                                                                                        1. Cardiology
                                                                                                                                                                                                                                                                                          1. Oncology
                                                                                                                                                                                                                                                                                            1. Pulmonary Arterial Hypertension
                                                                                                                                                                                                                                                                                              1. Hematology
                                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                                2. LATAM Intravenous to Subcutaneous Drug Repositioning Market, By End User
                                                                                                                                                                                                                                                                                                  1. Hospitals & Clinics
                                                                                                                                                                                                                                                                                                    1. Research Facilities
                                                                                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                                                                                      2. Brazil
                                                                                                                                                                                                                                                                                                        1. Brazil Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                                                                                                                                                          1. Devices
                                                                                                                                                                                                                                                                                                            1. Wearable SC Injectors
                                                                                                                                                                                                                                                                                                              1. Wearable SC Infusers
                                                                                                                                                                                                                                                                                                              2. Drugs
                                                                                                                                                                                                                                                                                                                1. Cancer Drugs
                                                                                                                                                                                                                                                                                                                  1. Blood Factors
                                                                                                                                                                                                                                                                                                                    1. Immunoglobulin G
                                                                                                                                                                                                                                                                                                                      1. Antibiotics
                                                                                                                                                                                                                                                                                                                        1. Remodulin
                                                                                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                                                                                        2. Brazil Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic Indication
                                                                                                                                                                                                                                                                                                                          1. Cardiology
                                                                                                                                                                                                                                                                                                                            1. Oncology
                                                                                                                                                                                                                                                                                                                              1. Pulmonary Arterial Hypertension
                                                                                                                                                                                                                                                                                                                                1. Hematology
                                                                                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                                                                                  2. Brazil Intravenous to Subcutaneous Drug Repositioning Market, By End User
                                                                                                                                                                                                                                                                                                                                    1. Hospitals & Clinics
                                                                                                                                                                                                                                                                                                                                      1. Research Facilities
                                                                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                                                                      2. Mexico
                                                                                                                                                                                                                                                                                                                                      3. Argentina
                                                                                                                                                                                                                                                                                                                                      4. Chile
                                                                                                                                                                                                                                                                                                                                      5. Colombia
                                                                                                                                                                                                                                                                                                                                      6. Rest of LATAM
                                                                                                                                                                                                                                                                                                                                  Get This Report

                                                                                                                                                                                                                                                                                                                                  Download Free Sample

                                                                                                                                                                                                                                                                                                                                  Our Clients:

                                                                                                                                                                                                                                                                                                                                  LG Electronics
                                                                                                                                                                                                                                                                                                                                  AMCAD Engineering
                                                                                                                                                                                                                                                                                                                                  KOBE STEEL LTD.
                                                                                                                                                                                                                                                                                                                                  Hindustan National Glass & Industries Limited
                                                                                                                                                                                                                                                                                                                                  Voith Group
                                                                                                                                                                                                                                                                                                                                  International Paper
                                                                                                                                                                                                                                                                                                                                  Hansol Paper
                                                                                                                                                                                                                                                                                                                                  Whirlpool Corporation
                                                                                                                                                                                                                                                                                                                                  Sony
                                                                                                                                                                                                                                                                                                                                  Samsung Electronics
                                                                                                                                                                                                                                                                                                                                  Qualcomm
                                                                                                                                                                                                                                                                                                                                  Google
                                                                                                                                                                                                                                                                                                                                  Fiserv
                                                                                                                                                                                                                                                                                                                                  Veto-Pharma
                                                                                                                                                                                                                                                                                                                                  Nippon Becton Dickinson
                                                                                                                                                                                                                                                                                                                                  Merck
                                                                                                                                                                                                                                                                                                                                  Argon Medical Devices
                                                                                                                                                                                                                                                                                                                                  Abbott
                                                                                                                                                                                                                                                                                                                                  Ajinomoto
                                                                                                                                                                                                                                                                                                                                  Denon
                                                                                                                                                                                                                                                                                                                                  Doosan
                                                                                                                                                                                                                                                                                                                                  Meiji Seika Kaisha Ltd
                                                                                                                                                                                                                                                                                                                                  LG Chemicals
                                                                                                                                                                                                                                                                                                                                  LCY chemical group
                                                                                                                                                                                                                                                                                                                                  Bayer
                                                                                                                                                                                                                                                                                                                                  Airrane
                                                                                                                                                                                                                                                                                                                                  BASF
                                                                                                                                                                                                                                                                                                                                  Toyota Industries
                                                                                                                                                                                                                                                                                                                                  Nissan Motors
                                                                                                                                                                                                                                                                                                                                  Neenah
                                                                                                                                                                                                                                                                                                                                  Mitsubishi
                                                                                                                                                                                                                                                                                                                                  Hyundai Motor Company

                                                                                                                                                                                                                                                                                                                                  We are featured on:

                                                                                                                                                                                                                                                                                                                                  WhatsApp
                                                                                                                                                                                                                                                                                                                                  Chat with us on WhatsApp
                                                                                                                                                                                                                                                                                                                                  Straits Research
                                                                                                                                                                                                                                                                                                                                  Address:
                                                                                                                                                                                                                                                                                                                                  105, Panchshil The Golden Bell,
                                                                                                                                                                                                                                                                                                                                  Koregaon Park Annexe, Mundhwa,
                                                                                                                                                                                                                                                                                                                                  Pune, Maharashtra 411036
                                                                                                                                                                                                                                                                                                                                  Contact Us:
                                                                                                                                                                                                                                                                                                                                  +1 646 905 0080 (U.S.)
                                                                                                                                                                                                                                                                                                                                  +91 8087085354 (India)
                                                                                                                                                                                                                                                                                                                                  +44 203 695 0070 (U.K.)

                                                                                                                                                                                                                                                                                                                                  sales@straitsresearch.com

                                                                                                                                                                                                                                                                                                                                  Quick Links
                                                                                                                                                                                                                                                                                                                                  Help
                                                                                                                                                                                                                                                                                                                                  Verified. Protected. Secure.
                                                                                                                                                                                                                                                                                                                                  Duns
                                                                                                                                                                                                                                                                                                                                  DMCA.com Protection Status
                                                                                                                                                                                                                                                                                                                                  lets-encrypt
                                                                                                                                                                                                                                                                                                                                  Secure Payments:
                                                                                                                                                                                                                                                                                                                                  Secure Payments
                                                                                                                                                                                                                                                                                                                                  Follow Us:
                                                                                                                                                                                                                                                                                                                                  www.straitsresearch.com © Copyright . All rights Reserved.